Population Genetics Technologies has received $1.2 million from the Wellcome Trust to study genetic predisposition to Alzheimer's disease in collaboration with researchers at Cardiff University in Wales, the company said this week.

During the two-year study funded under the award, PopGenTech will use its proprietary DNA selection and tagging technology to study rare variants in genes believed to be involved in Alzheimer's in patient samples.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.